Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Axsome And AXS-05: A Special Situation
02:25am, Monday, 02'nd May 2022
Current $1.2 billion valuation is unjustifiably low; conservative fundamental valuation yields $4+ billion fair value. AXS-05 has strong clinical data and a differentiated mechanism of action.
Why Axsome Therapeutics Stock Is Sinking Today
11:19am, Monday, 25'th Apr 2022
A thumbs-down from the FDA for AXS-07 in treating migraine is likely on the way.
Why Is Axsome Therapeutics (AXSM) Stock Down Today?
11:00am, Monday, 25'th Apr 2022
Axsome Therapeutics (AXSM) stock is falling hard on Monday following a report about an upcoming decision from the FDA this week. The post Why Is Axsome Therapeutics (AXSM) Stock Down Today?
Axsome Poised To Receive FDA Rejection For Its Migraine Candidate, Shares Fall
10:57am, Monday, 25'th Apr 2022
The FDA has informed that Axsome Therapeutics Inc (NASDAQ: AXSM) chemistry, manufacturing, and controls issues identified during the review of AXS-07 remain unresolved. The Company is seeking appro
Why Axsome Therapeutics Stock Is Falling Today
09:54am, Monday, 25'th Apr 2022
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday after the company reported it was informed by the U.S. Food and Drug Administration (FDA) that chemistry, manufacturing and co
Axsome Therapeutics to Report First Quarter 2022 Financial Results on May 2, 2022
07:00am, Monday, 25'th Apr 2022
Axsome to host conference call and webcast on Monday, May 2, 2022 at 8:00 AM Eastern Time NEW YORK, April 25, 2022 /PRNewswire/ -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical compan
The FDA Will Soon Give These 3 Healthcare Companies the Green Light
04:00pm, Friday, 22'nd Apr 2022
These Fool.com contributors see happy news in the future for Novavax, Axsome Therapeutics, and Novocure.
Axsome (AXSM) Surges on Potential Approval for AXS-05 Soon
12:02pm, Wednesday, 20'th Apr 2022
The FDA provides post-marketing requirements/commitments related to Axsome's (AXSM) under-review NDA for its lead pipeline candidate, AXS-05, for treating MDD. Investors anticipate an approval shortly
Why Is Axsome Therapeutics (AXSM) Stock Up Today?
12:05pm, Tuesday, 19'th Apr 2022
Axsome Therapeutics (AXSM) stock is on the rise Tuesday as the company edges closer to its first drug approval from the FDA. The post Why Is Axsome Therapeutics (AXSM) Stock Up Today?
Why Axsome Therapeutics Is Jumping Higher on Tuesday
10:43am, Tuesday, 19'th Apr 2022
A long-awaited FDA decision regarding AXS-05 finally has a timeline.
Axsome Therapeutics Stock Is Surging: Here's Why
09:45am, Tuesday, 19'th Apr 2022
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Tuesday after the company announced it received and agreed to Postmarketing Requirements/Commitments proposed by the U.S. Food and Dru
Axsome: A Growth Transition
12:04pm, Wednesday, 13'th Apr 2022
The recent Sunosi acquisition delivers pipeline synergy as well as making Axsome revenue positive. AXS07 is poised to gain FDA approval to better serve patients afflicted by migraines.
Axsome: A Speculative Buy, Undervalued Biotech With A Short-Term Catalyst
06:48am, Sunday, 03'rd Apr 2022
We are initiating coverage of Axsome Therapeutics with a BUY rating, TP of 120 USD.
3 CEOs to Invest In
09:00pm, Friday, 01'st Apr 2022
Looking for a healthcare stock with strong leadership? Our roundtable likes Immunocore, Axsome Therapeutics, and GlaxoSmithKline.
3 Top Health Care Stocks To Watch Today
04:30pm, Friday, 01'st Apr 2022
Could these health care stocks be healthy additions to your portfolio?
